| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-0684.1994.TB00115.X |
| P698 | PubMed publication ID | 7966229 |
| P50 | author | Robert J. Geraghty | Q42981886 |
| P2093 | author name string | Harper W | |
| Callahan M | |||
| Panganiban AT | |||
| Talbot KJ | |||
| P2860 | cites work | Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses | Q24561846 |
| High-efficiency transformation of mammalian cells by plasmid DNA | Q27860469 | ||
| The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit | Q27860669 | ||
| Genetic organization of a chimpanzee lentivirus related to HIV-1. | Q34028341 | ||
| Identification of a protein encoded by the vpu gene of HIV-1. | Q34163678 | ||
| Functional role of human immunodeficiency virus type 1 vpu. | Q34288200 | ||
| Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II | Q34352096 | ||
| A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity | Q36756570 | ||
| Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation | Q41603262 | ||
| A novel gene of HIV-1, vpu, and its 16-kilodalton product | Q42656133 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 146-150 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Journal of Medical Primatology | Q15755599 |
| P1476 | title | Cell type-dependence for Vpu function | |
| P478 | volume | 23 |
| Q37141248 | A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress |
| Q34623866 | Antiretroviral restriction factors in mice |
| Q35852056 | Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes |
| Q64093043 | CRISPR-mediated activation of endogenous BST-2/tetherin expression inhibits wild-type HIV-1 production |
| Q42690322 | Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherin |
| Q36237524 | Emerging drug targets for antiretroviral therapy |
| Q57019978 | Functional conservation and coherence of HIV-1 subtype A Vpu alleles |
| Q33670199 | Functional conservation and coherence of HIV-1 subtype A Vpu alleles. |
| Q33737672 | Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production |
| Q24523647 | Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. |
| Q37384691 | HIV-1 Vpu - an ion channel in search of a job. |
| Q24646984 | HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes |
| Q36687748 | Host restriction factors blocking retroviral replication |
| Q36548179 | Host restriction factors in retroviral infection: promises in virus-host interaction |
| Q28472771 | Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane |
| Q33768829 | Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef |
| Q34360874 | Intrinsic immunity: a front-line defense against viral attack |
| Q34134682 | Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release. |
| Q30397761 | Modulation of HIV-1-host interaction: role of the Vpu accessory protein |
| Q40015792 | Modulation of beta-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release |
| Q35914370 | Multiple restrictions of human immunodeficiency virus type 1 in feline cells |
| Q27657668 | NMR structural characterization of HIV-1 virus protein U cytoplasmic domain in the presence of dodecylphosphatidylcholine micelles |
| Q42133593 | Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release |
| Q26767362 | Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence |
| Q42234287 | Restriction of Retroviral Replication by Tetherin/BST-2. |
| Q80966892 | SARS coronavirus E protein forms cation-selective ion channels |
| Q33408799 | Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants |
| Q21559418 | Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2 |
| Q29547836 | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu |
| Q24605108 | The restriction factors of human immunodeficiency virus |
| Q39603635 | Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation |
| Q34391721 | Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production |
| Q26801489 | Vpu Protein: The Viroporin Encoded by HIV-1 |
| Q24644811 | Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism |
Search more.